Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7638552 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(4 months from now) | |
US7816396 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(4 months from now) |
Drugs and Companies using GLYCOPYRROLATE ingredient
Market Authorisation Date: 28 July, 2010
Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling
Dosage: SOLUTION;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic